Market Tracker

10/30 11:07am ET

Biomarin Pharmaceutical Inc (NASDAQ:BMRN)

82.29
Data as of 10:52am ET
 +1.73 / +2.15%
Today’s Change
55.04
Today|||52-Week Range
84.25
+16.97%
Year-to-Date

Today’s Trading

Previous close80.56
Today’s open80.32
Day’s range79.89 - 82.29
Volume172,997
Average volume (3 months)1,120,370
Market cap$11.9B
Dividend yield--
Data as of 10:52am ET, 10/30/2014

Growth & Valuation

Earnings growth (last year)-34.74%
Earnings growth (this year)+17.38%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+10.82%
P/E ratioNM
Price/Sales17.67
Price/Book8.62

Competitors

 Today’s
change
Today’s
% change
MNKMallinckrodt Plc-0.32-0.34%
ENDPEndo International P...+0.40+0.61%
JAZZJazz Pharmaceuticals...+1.28+0.76%
PCYCPharmacyclics Inc+2.36+1.79%
Data as of 11:07am ET, 10/30/2014

Financials

Next reporting dateFebruary 19, 2015
EPS forecast (this quarter)-$0.59
Annual revenue (last year)$548.4M
Annual profit (last year)-$176.4M
Net profit margin-32.15%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Jean-Jacques Bienaimé
Chief Financial Officer &
Executive Vice President
Daniel K. Spiegelman
Corporate headquarters
San Rafael, California

Forecasts